LONDON, UK / ACCESSWIRE / June 30, 2016 / Active Wall St announces the list of stocks for today’s research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Department Stores industry. Companies recently under review include J. C. Penney, Macy’s, Kohl’s, and TJX Cos.. See our complete report on J. C. Penney at:

http://www.activewallst.com/registration-3/?symbol=JCP

Today, AWS is promoting its equity research coverage. Get all of our research report free by signing up to http://www.activewallst.com/register/

The Department Stores space continues to present great opportunities despite the increasing popularity of e-commerce and changes in consumer demands and preferences. Let us see how these are affecting some of the big names in the industry. Register with us now for your free membership and more research reports at

http://www.activewallst.com/register/

Active Wall St looks at how each of the companies mentioned above have performed following its last close and over the last few trading sessions.

J. C. Penney Co. Inc. (NYSE: JCP)

Plano, Texas- based J. C. Penney Co. Inc.’s shares gained 2.19%, closing Wednesday’s trading session at $8.88. The stock recorded a trading volume of 16.48 million shares, which was above its three months average volume of 14.68 million shares. Shares of the Company have advanced 13.99% in the last month and 33.33% on an YTD basis. The stock is trading 5.01% above its 50-day moving average and 2.31% above its 200-day moving average. Additionally, shares of J. C. Penney, which through its subsidiary, J. C. Penney Corporation Inc., sells merchandise through department stores in the U.S., have a Relative Strength Index (RSI) of 58.12.

Macy’s Inc. (NYSE: M)

On Wednesday, shares in Cincinnati, Ohio- based Macy’s Inc. recorded a trading volume of 6.86 million shares, which was above their three months average volume of 6.67 million shares. The stock edged 2.74% higher, ending the day at $33.32. The Company’s shares have advanced 1.49% in the last month. The stock is trading below its 50-day moving average by 3.12%. Furthermore, shares of Macy’s, which together with its subsidiaries, operate stores, Websites, and mobile applications in the U.S., have an RSI of 48.73. Sign up for your research report on M at:

http://www.activewallst.com/registration-3/?symbol=M

Kohl’s Corp. (NYSE: KSS)

Menomonee Falls, Wisconsin headquartered Kohl’s Corp.’s stock finished the day 0.35% higher at $37.74 and with a total volume of 2.79 million shares traded. The Company’s shares have advanced 6.11% in the last one month. The stock is trading below its 50-day moving average by 1.90%. Additionally, shares of Kohl’s, which operates department stores in the U.S., have an RSI of 51.01. Register for free and download your research report on KSS at:

http://www.activewallst.com/registration-3/?symbol=KSS

The TJX Cos. Inc. (NYSE: TJX)

Shares in Framingham, Massachusetts headquartered The TJX Cos. Inc. ended yesterday’s session 2.36% higher at $76.31. The stock recorded a trading volume of 3.44 million shares, which was higher than its three months average volume of 3.25 million shares. The Company’s shares have advanced 0.25% in the last one month and 8.31% since the start of this year. The stock is trading 0.30% above its 50-day moving average and 4.75% above its 200-day moving average. Moreover, shares of TJX Cos., which operates as an off-price apparel and home fashions retailer in the U.S. and globally, have an RSI of 50.77. On June 24th, 2016, research firm Miller Tabak initiated a ‘Buy’ rating, issuing a target price of $91 on the Company’s stock. The research report on TJX is available for free at:

http://www.activewallst.com/registration-3/?symbol=TJX

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 441848

DOVER, DE / ACCESSWIRE / June 30, 2016 / Metatron Inc. (OTCPink: MRNJ): We are pleased to report our iOS app for iPhone and iPad based on the cannaboids.com brand has been approved by Apple and can now be found on iTunes. The Hemp Revolution – Cannaboids (CBD).

Download here: http://apple.co/299vKka

The Cannaboids app was created by our i-Mobilize app division and we were the first to put any Hemp related app on iTunes, and this is the first app to market CBD based products exclusively.

Similar to WeedMaps, the #1 Medical Marijuana app with an estimated $400,000 a month in sales according to Fast Company, our app will provide users with access and reviews to distributors of cannabinoid based products. The difference is our app will provide audio and video content as well and only feature products legal in all 50 states and most countries.

We expect our Android version to appear on Google Play soon, and will provide an update in the near future.
Up 17% since 2015 the estimated current legal cannabis market sales are expected to reach 6.7 Billion in 2016. ArcView Research expects the legal cannabis market to show a compound annual growth rate of nearly 30% over the next few years, reaching 21.8 billion in total annual sales by 2020, which is larger than the NFL.

In other news:

Our first YouTube paid subscription site MarkSargent.com is live and we are pleased with its performance. Be sure to sign up now, free for a limited time: MarkSargent.com

Mark Sargent was mentioned this week in the July 28th UK Guardian: “An American named Mark Sargent, formerly a professional video-gamer and software consultant, has had millions of views on YouTube for his Flat Earth Clues video series.”

Metatron is in talks with multiple parties to design similar sites and we plan on creating our own content sites and integrating them into our existing portfolio of 700+ apps.

Shareholders have asked if we are going to do a R/S, the answer is not this year and have no plans to do so. The details on the announced non-dilutive dividend will be communicated in the near future.

Metatron provides digital content distribution across most major mobile device platforms. Through its app division iMobilize, the company was an early pioneer in the App industry. Metatron conceives, creates, and monetizes content for its customers in order to reach a global audience.

We have 700+ apps on sale now with over 3 million in sales and downloads. Our focus lies in the health, fitness, and entertainment categories. High profile clients include Eckhart Tolle, Mark Sargent, Jafree Ozwald, Sounds True, Gary Zukav, Denise Druce, Mind Motivations, Effective Learning Systems, Travelvideostore.com and many others.

Website: http://metatroninc.com/
Facebook: http://www.facebook.com/metatroninc
Facebook: http://www.facebook.com/iMobilize
News: https://metatroninc.wordpress.com
Twitter: http://twitter.com/metatroninc

Apps:

iTunes: https://itunes.apple.com/us/artist/i-mobilize-inc./ id325075390
Google Play: https://play.google.com/store/apps/ developer?id=Metatron+Inc

Forward-Looking Statements: Any statements made in this press release which are not historical facts contain certain forward-looking statements, as such term is defined in the Private Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results of the specific items described in this release, and the company’s operations generally, to differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company’s need for additional financing, which is not assured and which may result in dilution of shareholders, the company’s status as a small company with a limited operating history, dependence on third parties and the continuing popularity of the iOS operating system, general market and economic conditions, technical factors, receipt of revenues, and other factors, many of which are beyond the control of the company. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such statements, and we disclaim any obligation to update information contained in any forward-looking statement. Metatron retained Pacific Equity Alliance LLC by issuing Integrative Business Alliance LLC 100m rule 144 for 1 year consulting services.

Metatron does not grow, sell or distribute any substances that violate United States Law or the controlled substance act.

CONTACT:

Website: http://www.metatroninc.com
Phone: 302-861-0431

Press Release Information:

Investor Relations: PACIFIC EQUITY ALLIANCE LLC
Investor Contact(s): Zachary R. Logan / Grady Powell
Contact phone: 858.886.7238
info@pacif8ificequityusa.com

Zachary R. Logan
President

PACIFIC EQUITY ALLIANCE LLC
WWW.PACIFICEQUITYUSA.COM
WWW.INVESTORSPOTLIGHTDAILY.COM
858.886.7237
858.886.7238

Disclaimer: Pacific Equity Alliance, LLC. is an Independent Investor Relations firm that provides information on selected publicly traded companies. Pacific Equity Alliance, LLC. is not a United States Securities Dealer or Broker or United States registered Investment Adviser. This email letter and any and all attachments and related documents are never considered to be a solicitation for any purpose in any form or content. Pacific Equity Alliance, LLC.’s Affiliates, Officers, Directors and Employees will buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own due diligence before investing in any of the stocks mentioned above. Upon receipt of these documents you, as the Recipient, hereby acknowledge this Warning and Disclaimer. These Confidential communications are protected under GrammLeach-Bailey Act 15 USC, Sub chapter 1, sections 6801-6809 and other laws addressing the disclosure of Non-Public Personal Information.

Confidential: The contents of this message, together with any attachments, are intended only for the use of the individual or entity to which they are addressed and may contain information that is legally privileged, confidential and exempt from disclosure. This communication is for information purposes only and should not be regarded as an offer to sell or as a solicitation of an offer to buy any financial product, an official confirmation of any transaction, or as an official statement of the Sender or its Principals. Email transmission cannot be guaranteed to be secure or error-free. The Sender, its affiliates and or assigns does not represent that this information is complete or accurate and it should not be relied upon as such. All information is subject to change without notice. If you are not the intended recipient, you are hereby notified that any dissemination, distribution, or copying of this message, or any attachment, is strictly prohibited. If you have received this message in error, please notify the original sender by return E-mail and delete this message, along with any attachments, from your computer.

SOURCE: Metatron Inc.

ReleaseID: 441828

LONDON, UK / ACCESSWIRE / June 30, 2016 / Active Wall St announces the list of stocks for today’s research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Insurance Brokers industry. Companies recently under review include Marsh & McLennan, Arthur J. Gallagher, Aon PLC, and Willis Towers Watson. See our complete report on Marsh & McLennan at:

http://www.activewallst.com/registration-3/?symbol=MMC

Today, AWS is promoting its equity research coverage. Get all of our research report free by signing up to http://www.activewallst.com/register/

Many operators in the Insurance Brokers segment are transforming their business models and reinventing their marketing strategies in order to keep pace with evolving consumer needs and demands. Let us see how this is affecting some of the big names in the industry. Register with us now for your free membership and more research reports at

http://www.activewallst.com/register/

Active Wall St takes a brief look at how each of the companies mentioned above have performed at the close yesterday and over the last few trading sessions.

Marsh & McLennan Cos. Inc. (NYSE: MMC)

At the close on Wednesday, shares in New York headquartered professional services firm, Marsh & McLennan Cos. Inc., rose 1.80%, ending the day at $66.77. The stock recorded a trading volume of 2.24 million shares, which was higher than its three months average volume of 1.71 million shares. The Company’s shares have advanced 1.06% in the last one month, 10.40% in the previous three months, and 21.77% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 3.12% and 15.79%, respectively. Moreover, shares of Marsh & McLennan, which provides advice and solutions in the areas of risk, strategy, and people globally, have a Relative Strength Index (RSI) of 55.73.

Arthur J. Gallagher & Co. (NYSE: AJG)

Shares in Itasca, Illinois headquartered Arthur J Gallagher & Co. ended the day 2.39% higher at $46.36 and with a total volume of 952,962 shares traded. In the previous three months and since the start of this year, the stock has gained 5.05% and 15.21%, respectively. The Company’s shares are trading above their 200-day moving average by 9.35%. Furthermore, shares of Arthur J Gallagher, which together with its subsidiaries, provides insurance brokerage and risk management services in the U.S. and globally, have an RSI of 47.75. Visit us today and download your complimentary research report on AJG at:

http://www.activewallst.com/registration-3/?symbol=AJG

Aon PLC (NYSE: AON)

On Wednesday, shares in London, the U.K. headquartered Aon PLC finished 2.42% higher at $106.43. A total volume of 1.33 million shares was traded, which was above their three months average volume of 1.18 million shares. The stock has advanced 2.22% over the previous three months and 16.19% on an YTD basis. The Company’s shares are trading above their 50-day and 200-day moving averages by 0.14% and 10.21%, respectively. Additionally, shares of Aon, which provides risk management services, insurance and reinsurance brokerage, and human resource consulting and outsourcing services globally, have an RSI of 48.86. The research report on AON is available for free at:

http://www.activewallst.com/registration-3/?symbol=AON

Willis Towers Watson PLC (NASDAQ: WLTW)

London, the U.K. based Willis Towers Watson PLC’s shares recorded a trading volume of 1.05 million shares at the end of yesterday’s session, which was higher than their three months average volume of 780,160 shares. The stock closed the day at $121.00, gaining 2.93%. The Company’s shares have advanced 2.41% in the previous three months and 1.69% since the start of this year. The stock is trading above its 200-day moving average by 2.11%. Additionally, shares of Willis Towers Watson, which operates as an advisory, broking, and solutions Company serving large companies, and mid-market and small businesses globally, have an RSI at 44.80. Complimentary research on WLTW is accessible at:

http://www.activewallst.com/registration-3/?symbol=WLTW

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated directly or indirectly for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 441852

LONDON, UK / ACCESSWIRE / June 30, 2016 / Active Wall ST announces the list of stocks for today’s research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Specialty Chemicals industry. Companies recently under review include Amyris, Methanex, Valspar, and International Flavors & Fragrances. See our complete report on Amyris at:

http://www.activewallst.com/registration-3/?symbol=AMRS

Today, AWS is promoting its equity research coverage. Get all of our research report free by signing up to http://www.activewallst.com/register/

Rapid global industrialization and increasing demand for chemicals are opening up opportunities for the Specialty Chemicals industry, which is expected to grow at a compound annual growth rate (CAGR) of 5.4% by 2020. Let us see how these are affecting some of the big names in the industry. Register with us now for your free membership and more research reports at:

http://www.activewallst.com/register/

Active Wall St takes a brief technical look at how each of the aforementioned companies have fared over the last few trading sessions.

Amyris Inc. (NASDAQ: AMRS)

On Wednesday, shares in Emeryville, California headquartered Amyris Inc. recorded a trading volume of 9.34 million shares, which was higher than their three months average volume of 1.19 million shares. The stock ended the day at $0.41, surging 9.18%. The Company’s shares are trading below their 50-day moving average by 39.35%. Furthermore, shares of Amyris, which provides various alternatives to a range of petroleum-sourced products globally, have a Relative Strength Index (RSI) of 33.05.

Methanex Corp. (NASDAQ: MEOH)

Vancouver, Canada headquartered Methanex Corp.’s stock finished yesterday’s session 3.36% higher at $30.16 and with a total volume of 841,841 shares traded. The Company’s shares are trading below their 50-day moving average by 5.32%. Shares of the Company, which produces and supplies methanol in the Asia Pacific, North America, Europe, and South America, have an RSI of 44.62. Sign up and download your free research report on MEOH at:

http://www.activewallst.com/registration-3/?symbol=MEOH

The Valspar Corp. (NYSE: VAL)

At the closing bell on Wednesday, shares in Minneapolis, Minnesota headquartered The Valspar Corp. saw a slight drop of 0.21%, ending the day at $107.38. The stock recorded a trading volume of 309,780 shares. The Company’s shares have advanced 0.64% in the previous three months and 30.38% since the start of this year. The stock is trading 0.15% above its 50-day moving average and 21.19% above its 200-day moving average. Moreover, shares of Valspar, which develops, manufactures, and distributes a range of coatings, paints, and related products globally, have an RSI of 44.44. Register for free and download your research report on VAL at:

http://www.activewallst.com/registration-3/?symbol=VAL

International Flavors & Fragrances Inc. (NYSE: IFF)

New York-based International Flavors & Fragrances Inc.’s stock ended the day 2.20% higher at $123.81. A total volume of 845,600 shares was traded, which was above their three months average volume of 569,830 shares. The Company’s shares have gained 9.31% over the previous three months and 4.45% on an YTD basis. The stock is trading 7.46% above its 200-day moving average. Additionally, shares of International Flavors & Fragrances, which together with its subsidiaries, creates, manufactures, and supplies flavors and fragrances for use in consumer products, have an RSI of 47.11. IFF free research is just a click away at:

http://www.activewallst.com/registration-3/?symbol=IFF

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 441855

LONDON, UK / ACCESSWIRE / June 30, 2016 / Active Wall St announces the list of stocks for today’s research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Application Software industry. Companies recently under review include FireEye, salesforce.com, Adobe Systems, and Imperva. See our complete report on FireEye at:

http://www.activewallst.com/registration-3/?symbol=FEYE

Today, AWS is promoting its equity research coverage. Get all of our research report free by signing up to http://www.activewallst.com/register/

A steady growth is expected for the Application Software space in the next couple of years given the advancement of new technologies. Let us see how this is affecting some of the big names in the industry. Register with us now for your free membership and more research reports at

http://www.activewallst.com/register/

Active Wall St looks at the performance of the aforementioned companies over the last few trading sessions.

FireEye Inc. (NASDAQ: FEYE)

Shares in Milpitas, California headquartered FireEye Inc. ended Wednesday’s session at $15.88, surging 4.89%. The stock recorded a trading volume of 4.19 million shares. The Company’s shares are trading 0.68% above their 50-day moving average. Moreover, shares of FireEye, which provides cybersecurity solutions for detecting, preventing, analyzing, and resolving cyber-attacks, have a Relative Strength Index (RSI) of 47.47.

salesforce.com Inc. (NYSE: CRM)

San Francisco, California headquartered salesforce.com inc.’s stock gained 1.87%, closing the day at $79.00. A total volume of 5.49 million shares was traded, which was above their three months average volume of 3.64 million shares. The Company’s shares have advanced 7.00% in the previous three months and 0.77% since the start of this year. The stock is trading 5.43% above its 200-day moving average. Additionally, shares of salesforce.com, which provides enterprise cloud computing solutions, with a focus on customer relationship management to various businesses and industries globally, have an RSI of 45.34. On June 15th, 2016, research firm BMO Capital Markets initiated an ‘Outperform’ rating, issuing a target price of $98 on the Company’s stock. The complimentary research on CRM can be downloaded at:

http://www.activewallst.com/registration-3/?symbol=CRM

Adobe Systems Inc. (NASDAQ: ADBE)

On Wednesday, shares in San Jose, California headquartered Adobe Systems Inc. recorded a trading volume of 2.96 million shares, which was higher than their three months average volume of 2.69 million shares. The stock ended the day 2.09% higher at $94.39. The Company’s shares have advanced 0.63% over the previous three months and 0.48% on an YTD basis. The stock is trading above its 200-day moving average by 4.54%. Furthermore, shares of Adobe Systems, which operates as a diversified software Company globally, have an RSI of 45.91. On June 22nd, 2016, research firm UBS reiterated its ‘Buy’ rating with an increase of the target price to $122 a share from $114 a share for the Company’s stock. Register for free and access the latest research report on ADBE at:

http://www.activewallst.com/registration-3/?symbol=ADBE

Imperva Inc. (NYSE: IMPV)

Redwood Shores, California headquartered Imperva Inc.’s stock saw a slight decline of 0.74%, finishing yesterday’s session at $41.64. A total volume of 1.13 million shares was traded, which was above their three months average volume of 676,710 shares. The Company’s shares have advanced 9.06% in the last one month. The stock is trading above its 50-day moving average by 3.37%. Additionally, shares of Imperva, engages in the development, market, sale, and support of cyber security solutions that protect business critical data and applications in the cloud or on premises globally, have an RSI of 49.95. The complete research report on IMPV is available for free at:

http://www.activewallst.com/registration-3/?symbol=IMPV

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated directly or indirectly for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author “) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 441851

LONDON, UK / ACCESSWIRE / June 30, 2016 / Active Wall St announces its coverage of market signals with highlight on these most active stocks from Wednesday’s session: The Barrick Gold Corporation (NYSE: ABX), Yamana Gold, Inc. (NYSE: AUY), and Gold Fields Ltd. (NYSE: GFI). Register with us now for your free membership and get more on our signal alerts at:

http://www.activewallst.com/register/

Gold Performance

On Wednesday, June 29, 2016, Gold prices rose as continued concerns over Britain leaving the European Union sent investors into safe-haven investing mode. Gold also benefitted from the declining U.S Dollar. The precious metal for August delivery settled up 0.7% at $1,326.90 a troy ounce on the Comex division of the New York Mercantile Exchange. In the medium term, gold is expected to remain strong under the unlikelihood that the Fed will raise rates in the coming meetings.

Today, AWS is promoting its market signals coverage with emphasis on ABX, AUY, and GFI. Get all of our reports for free by signing up to http://www.activewallst.com/register/.

Below we take a look at some of the most active stocks in the Gold Sector.

Most Active – Barrick Gold

On Wednesday, shares in The Barrick Gold Corp. recorded heavy trading volume of 24.45 million shares, higher than its three months average volume of 19.24 million shares. Barrick Gold’s shares ended the trading session at $20.77, up 0.68% from its previous closing price. The stock moved between an intraday range of $20.74 and $21.35. Shares of the company are up 23.85% in the last one month and 182.18% on YTD basis. The company’s stock is trading 13.29% above its 50-day moving average and 75.76% above its 200-day moving average.

Most Active – Yamana Gold

Shares of Yamana Gold, Inc. finished Wednesday’s trading session 5.67% up at $5.22. A total of 12.99 million shares were traded, which was below its three months average volume of 15.74 million shares. The stock moved between $5.04 and $5.30 during the session. Over the last one month and the last three months, Yamana’s shares have increased 25.00% and 71.88%, respectively. Since the beginning of 2016, the company’s stock has advanced 181.41%. The company’s shares are trading 11.97% above its 50-day average and 80.51% above its 200-day moving average.

Most Active – Gold Fields

On Wednesday, shares in Gold Fields Ltd. oscillated between an intra low of $4.62 and a session high of $4.96 before ending the day at $4.91, up 10.84%. Gold fields’ shares recorded a trading volume of 8.14 million shares, which was above its three months average volume of 6.38 million shares. Shares of GFI have increased 24.62% in the last three months and 77.86% on YTD basis. The stock is trading 17.57% above its 50-day moving average; while it is 42.85% above its 200-day moving averages.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 441853

LONDON, UK / ACCESSWIRE / June 30, 2016 / Active Wall ST announces its post-earnings coverage on General Mills Inc. (NYSE: GIS). The company announced its Q4 FY16 and FY 2016 results on Wednesday, June 29, 2016. The Cheerios brand maker posted earnings and revenue results that beat Wall Street’s estimates, while the company also raised its cost savings projection to $600 million and boosted its quarterly dividend by 4%. Register with us now for your free membership and see our complete earnings coverage on this equity at:

http://www.activewallst.com/register/

Today, AWS is promoting its earnings coverage on GIS. Get all of our free coverage by signing up to http://www.activewallst.com/registration-3/?symbol=GIS.

Earnings Reviewed

For the period ended May 29, 2016, General Mills reported a profit of $379.6 million, or $0.62 per share, up from $186.8 million, or $0.30 per share, in the year ago period. Adjusted earnings fell to $0.66 from $0.75 in the year ago period, topping analysts’ expectation of adjusted earnings of $0.60. Revenue declined 8.6% on y-o-y basis to $3.93 billion. Weak demand for its Yogurt brand, strong U.S. dollar, and the completion of the sale of Green Giant frozen foods line to B&G Foods Inc. (NYSE: BGS) weighed on its results. For Q4 FY16, U.S. retail segment net sales declined 12% to $2.2 billion, while international net sales fell 1% to $1.2 billion.

Reorganisation Helps Profitability in Cereals

General Mills has been under pressure lately as its U.S. sales and profits have been impacted by changing consumer food preferences. The Golden Valley-based food processing giant has tried to reorganize itself as consumers have become more conscious about their eating habits.

In September 2014 General Mills acquired organic snack maker Annie’s Inc. and in September 2015 it sold the Green Giant’s business. Furthermore, the company has refurbished its own cereal products line; it has made Cheerios gluten free, removed artificial colours and sweeteners from Trix, and introduced Annie’s organic cereals. This has shown on its top line for Q4 FY16 as U.S. retail sales of General Mills’ cereal rose 3%.

Cost Cutting Boosts Margin Target

To counter sluggish sales growth, General Mills is rapidly and aggressively cutting costs to increase profitability. The company has forecasted that by FY 2018 its cost-reduction and organizational efficiency initiatives, as well as administrative cost reductions will generate annual savings of $600 million, up from the prior target of $500 million, the company also said that it is taking further steps to streamline its operations. It now expects its adjusted operating profit margin to expand from the current 16.8% to 20% by FY 2018.

New Focus

General Mills said that it would be more stringent in investing in business upon the potential, the company said it would invest more heavily in what it terms as “growth” businesses which accounts for about 75% of the company’s overall revenue and operating profit, consisting of Cereal, natural and organic brands, yogurts, and Mexican food among others in the U.S. The company also announced that it will renew its focus on reducing products, consisting of Betty Crocker baking mixes, Pillsbury refrigerated dough and Progresso soup among others, which have slower growth, and prioritize the most profitable ones in what it terms the “foundational” category.

Outlook

Going forward, General Mills expects organic net sales for FY 2017 to be flat or down 2% y-o-y, and earnings per share to increase 6% to 8%. For FY 2018, the company expects earnings growth by low double digits.

Dividend

The maker of Betty Crocker and Bisquick food products raised its quarterly dividend by 4% to $0.48. The dividend is payable on August, 01, 2016 to shareholders of record on July 11, 2016.

Stock Market Reaction

General Mills shares surged 3.19% to finish the trading session at $67.86 on Wednesday, post its earnings release. Since the beginning of the year, the company’s shares have advanced 19.47% as compared to the S&P 500 which is up 1.31% during the same time frame.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 441850

NEW YORK, NY / ACCESSWIRE / June 30, 2016 / The Biotech Industry received a boost last month after Pfizer Inc. announced its acquisition of Anacor Pharmaceuticals Inc. and its eczema gel, crisaborole, for $5.2 billion. Under the terms of the deal, Pfizer agreed to pay $99.25 per share in cash for Anacor, which represented a 55 percent premium to Anacor’s closing price of $64.03 on May 13th. The transaction has already received approval from both the company’s board of directors and is expected to be completed in the third quarter of 2016. The acquisition could potentially kick start merger and acquisition activity within the biotech industry as larger pharmaceutical and biotech companies will also look to boost revenues through acquisitions. Register with us now for your free membership and gain access to our biotech reports at: www.rdinvesting.com. Today we feature reports on ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), Exelixis, Inc. (NASDAQ: EXEL), Medivation Inc. (NASDAQ: MDVN) and Novavax, Inc. (NASDAQ: NVAX).

“A lot of assets have gotten very cheap. This could kick-start mergers and acquisitions,” says Mindy Perry, a health-care sector portfolio manager for Manulife Asset Management.

“Large pharma and biotech companies need to start showing revenue growth, and the only way to do that is to buy a company that has a drug or will soon,” says Brad Loncar, of Loncar Investments.

ACADIA
Pharmaceuticals Inc. (NASDAQ: ACAD)

Get Your Up-To-Date ACADIA
Pharmaceuticals Research Report at www.rdinvesting.com/company/ACAD

ACADIA Pharmaceuticals’ shares gained 2.27 percent to close at $32.38 a share on Wednesday. The stock traded between $31.61 and $32.72 on volume of 1.87 million shares traded. The stock appears to be facing some resistance at $34.00 and $39.88 with some support at $32.24 and $29.14. ACADIA is focused on the development and commercialization of innovative medicines to address unmet medical needs associated with central nervous system disorders. On April 29th, the U.S. Food and Drug Administration (FDA) approved ACADIA’s NUPLAZID (pimavanserin) for treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. Acadia hopes to begin selling NUPLAZID in the United States by June 2016. Shares of ACADIA Pharmaceuticals have fallen approximately 9.2 percent year-to-date and are down roughly 9.1 percent in the past month.

Exelixis, Inc. (NASDAQ: EXEL)

Get Your Up-To-Date Exelixis Research Report at www.rdinvesting.com/company/EXEL

Exelixis’ shares increased 0.26 percent to close at $7.80 a share Wednesday. The stock traded between $7.63 and $7.90 on volume of 6.25 million shares traded. The stock appears to be facing some resistance at $8.28 with some support at $7.60 and $6.75. Exelixis’ share price gained 11.2% earlier this month after the company reported positive trial results for its advanced kidney cancer treatment CABOMETYX. “Patients whose kidney cancer has spread to their bones traditionally have a poorer prognosis and worse treatment outcomes compared with those who do not have bone involvement,” Bernard Escudier, M.D., chair, Genitourinary Oncology Committee, Institut Gustave Roussy, said in a statement. “CABOMETYX demonstrated a clinically meaningful benefit for those with bone metastases, which is encouraging for physicians and patients who are seeking additional therapeutic options.” Shares of Exelixis have gained approximately 38.3 percent year-to-date and are up roughly 23.0 percent in the past month.

Medivation Inc. (NASDAQ: MDVN)

Get Your Up-To-Date Medivation Research Report at www.rdinvesting.com/company/MDVN

Medivation’s shares jumped 5.47 percent to close at $60.95 a share Wednesday. The stock traded between $59.20 and $60.99 on volume of 3.70 million shares traded. The stock appears to be facing some resistance at $61.52 and $71.63 with some support at $58.59 and $54.50. Medivation has been in the headlines in recent months as Sanofi has made multiple bids to acquire the company. Medivation’s lead drug Medivation’s lead product candidate Xtandi was approved by the FDA in 2012 as a treatment for metastatic prostate cancer. Sales of Xtandi totaled $547.6 million globally in the first quarter of 2016, an increase of 53 percent year-over-year. Shares of Medivation have gained approximately 26.1 percent year-to-date and are up roughly 0.5 percent in the past month.

Novavax, Inc. (NASDAQ: NVAX)

Get Your Up-To-Date Novavax Research Report at www.rdinvesting.com/company/NVAX

Novavax’s shares increased 2.87 percent to close at $7.17 a share Wednesday. The stock traded between $6.90 and $7.25 on volume of 6.77 million shares traded. The stock appears to be facing some resistance at $7.39 with some support at $7.13 and $6.70. On May 25th, the FDA granted Fast Track Designation to Novavax’ RSV F-Protein nanoparticle vaccine candidate (RSV F Vaccine) for the protection of older adults (60 years of age and older). “The FDA’s granting of Fast Track designation for our RSV F Vaccine in older adults underscores its recognition of RSV as a significant unmet medical need in this large population segment,” said Stanley C. Erck, President and CEO. “This joins our prior Fast Track designation for the RSV F Vaccine for the protection of infants via maternal immunization. Fast Track designation could allow for an expedited timeline to licensure, accelerating the access to this vaccine for the most vulnerable populations.” Shares of Novavax have fallen approximately 14.5 percent year-to-date, but have rallied roughly 22.3 percent in the past month.

Research Driven
Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Hemal K. Gandhi, a CFA® charter holder. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 441820

LONDON, UK / ACCESSWIRE / June 30, 2016 / Active Wall St announces the list of stocks for today’s research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Medical Appliances & Equipment industry. Companies recently under review include Boston Scientific, Abbott Laboratories, Medtronic, and Hologic. See our complete report on Boston Scientific at:

http://www.activewallst.com/registration-3/?symbol=BSX

Today, AWS is promoting its equity research coverage. Get all of our research report free by signing up to http://www.activewallst.com/register/

Despite a slowdown this year, steady growth is expected for the Medical Appliances and Equipment industry given the increasing demand for healthcare. Let us see how this is affecting some of the big names in the industry. Register with us now for your free membership and more research reports at

http://www.activewallst.com/register/

Active Wall St takes a brief technical look at how each of the companies mentioned above have fared over the last few trading sessions.

Boston Scientific Corp. (NYSE: BSX)

Marlborough, Massachusetts headquartered Boston Scientific Corp.’s shares climbed 3.04% and finished Wednesday’s trading session at $23.03. A total volume of 12.69 million shares was traded, which was above their three months average volume of 11.30 million shares. In the past month and the previous three months, the stock has advanced 1.41% and 22.43%, respectively. Additionally, the Company’s shares have gained 24.89% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 4.13% and 22.09%, respectively. Moreover, shares of Boston Scientific, which develops, manufactures, and markets medical devices for use in various interventional medical specialties globally, have a Relative Strength Index (RSI) of 56.31. On June 09th, 2016, research firm Guggenheim initiated a ‘Buy’ rating for the Company’s stock.

Abbott Laboratories (NYSE: ABT)

On Wednesday, shares in Abbott Park, Illinois headquartered Abbott Laboratories recorded a trading volume of 8.37 million shares, and ended the session 2.69% higher at $38.57. The stock is trading 1.38% below its 50-day moving average. Shares of the Company, which manufactures and sells health care products globally, have an RSI of 52.02. On June 21st, 2016, research firm Edward Jones upgraded the Company’s stock ratings from ‘Hold’ to ‘Buy’. Sign up and download your free research report on ABT at:

http://www.activewallst.com/registration-3/?symbol=ABT

Medtronic PLC (NYSE: MDT)

Shares in Dublin, Ireland headquartered Medtronic PLC closed the day at $85.45, gaining 1.56%. The stock recorded a trading volume of 5.12 million shares. The Company’s shares have advanced 6.18% in the last one month, 13.93% over the previous three months, and 11.65% since the start of this year. The stock is trading 4.60% above its 50-day moving average and 12.02% above its 200-day moving average. Additionally, shares of Medtronic, which manufactures and sells device-based medical therapies globally, have an RSI of 59.47. On June 09th, 2016, research firm Guggenheim initiated a ‘Neutral’ rating for the Company’s stock. Register for free and download your research on MDT at:

http://www.activewallst.com/registration-3/?symbol=MDT

Hologic Inc. (NASDAQ: HOLX)

At the closing bell yesterday, shares in Marlborough, Massachusetts headquartered Hologic Inc. ended 2.13% higher at $34.06 and with a total volume of 3.28 million shares traded. The stock is trading below its 50-day moving average by 1.05%. Shares of the Company, which develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the U.S., Europe, the Asia-Pacific, and globally, have an RSI of 50.67. HOLX free research report is just a click away at:

http://www.activewallst.com/registration-3/?symbol=HOLX

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated directly or indirectly for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 441846

LONDON, UK / ACCESSWIRE / June 30, 2016 / Active Wall ST announces its post-earnings coverage on Monsanto Co. (NYSE: MON). The company announced its Q3 FY16 earnings results on Wednesday, June 29, 2016, reporting a steeper than expected decline in third quarter profit and revenue, as it continues to battle agricultural headwinds. Register with us now for your free membership and see our complete earnings coverage on this equity at:

http://www.activewallst.com/register/

Today, AWS is promoting its earnings coverage on MON. Get all of our free coverage by signing up to http://www.activewallst.com/registration-3/?symbol=MON

Earnings Reviewed

For the three month ended on May 31, 2016, Monsanto’s overall profit tumbled 37% to $717 million, or $1.63 per share, as compared to profit of $1.14 billion, or $2.39 per share, in the year ago period. Adjusted earnings of $2.17 per share were lower than analysts’ consensus estimates of $2.40 per share. For Q3 FY16, revenue declined 8.5% to $4.19 billion as compared to revenue of $4.58 billion in Q3 FY15, also missing analysts’ estimates of $4.49 billion.

In Q3 FY16, revenue from the agricultural productivity segment plunged by almost 30% as compared to Q3 FY15. This was primary attributed to the discontinuation of its licensing deal with Scotts, which generated $274 million in revenue in Q3 FY15. Elsewhere, the key seeds and genomics segment held up better. The overall segment revenue rose slightly, with weak sales of soybeans and cotton offset by corn and Monsanto’s other-crops category.

The seeds and pesticides maker is grappling with a multiyear slide in major crop prices that has reduced farmers’ income and has forced farm supply companies to tighten their own belts. The company’s profit has also come under pressure from strong U.S. dollar and price cuts triggered by competitors. Monsanto is also facing additional challenges such as declining price of the herbicide, glyphosate, restrictions by the Indian government on cottonseed pricing, and a continuing wait for approval of a new soybean variety from the European Union which Monsanto hopes to be a blockbuster.

Negotiation on Bayer Deal

The disappointing quarterly results will be seen as a setback to Monsanto’s efforts to negotiate a higher bid from German conglomerate Bayer, which in May 2016 offered $122 per share, worth $62 billion including $8.3 billion of net debt. Monsanto deemed the offer as too low, but signalled that it was open to negotiating further. Monsanto said it has been in talks with Bayer over the last few weeks, but gave no official update. The company has also held talks with others as an alternative to the Bayer’s offer.

Negotiations with Bayer could be complicated by headwinds the industry is facing, Bayer’s share price has declined recently, while the Euro has plunged against the dollar following Brexit. Bayer had planned to finance 25% of the deal by selling shares, while the bulk of the cash will be raised using U.S. dollar-denominated bonds.

Guidance

Monsanto expects its FY 2016 earnings to come in at the low end of its guidance range of between $4.40 and $5.10 per share. The company said it remains on track to deliver $165 million to $210 million in savings from its restructuring actions in FY 2016, primarily benefiting operating expenses. Beyond FY 2016, the company said it continues to target a mid-teens compounded annual growth rate in earnings per share from FY 2017, now advancing to FY 2021.

Stock Market Reaction

Monsanto’s shares gained 2.40% to finish the trading session at $103.52 on Wednesday, post its earnings release. Since the beginning of the year the company’s shares have gained 6.32%.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated directly or indirectly for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 441858